Physician-Scientists: The Bridge between Medicine and Science

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Microenvironment".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 354

Special Issue Editors


E-Mail Website
Guest Editor
1. FirmoLab Fondazione F.I.R.M.O., Florence, Italy
2. Department of Biological, Experimental and Clinical Science, University of Florence, Florence, Italy
Interests: bone metabolism; osteoporosis; skeletal rare diseases; multiple endocrine neoplasia; hypoparathyroidism; hyperparathyroidism

E-Mail Website
Guest Editor
1. The Laboratory for Applied Cancer Research, Rambam Healthcare Campus, Clinical Research Institute at Rambam, Rappaport Institute of Medicine and Research, The Technion, Israel Institute of Technology, Haifa, Israel
2. Department of Otolaryngology Head and Neck Surgery, The Head and Neck Center, Rambam Healthcare Campus, Clinical Research Institute at Rambam, Rappaport Institute of Medicine and Research, The Technion, Israel Institute of Technology, Haifa, Israel
Interests: tumor microenvironment; nano vesicles; exosomes; tumor associate macrophages; pancreas cancer; head and neck cancer; neural invasion; RET; healthcare management
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

A physician-scientist is traditionally a holder of a medical degree and a Doctor of Philosophy, also known as an MD-PhD. Compared to other clinicians, physician-scientists invest significant time and professional effort in scientific research and spend correspondingly less time in direct clinical practice, with ratios of research to clinical time ranging from 50/50 to 80/20. As physician-scientists, going back and forth between medicine and science is natural and almost necessary. Physician-scientists are often employed by academic or research institutions where they drive innovation across a wide range of medical specialties and may also use their extensive training to focus their clinical practices on specialized patient populations, such as those with rare genetic diseases or cancers. Here, we provide a platform of the state of the art of cell biology for physician-scientists to display their research results and promote communication in this field.

Prof. Dr. Maria Luisa Brandi
Prof. Dr. Ziv Gil
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop